Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Maves vs Vida Health

Maves
Graded #89

Higher grade

vs+16.599999999999994
Vida Health
Graded #446

Lower grade

The verdict

Maves takes it — 71.8/100 to 55.2/100.

Maves grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Maves, operating under parent company Homera Health, is a performance-framed telehealth platform offering compounded semaglutide and tirzepatide for weight loss plus sermorelin for anti-aging, with…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMaves +39
84
45
Dose & formulationMaves +25
65
40
Clinical oversightMaves +1
76
75
Labs & monitoringVida Health +9
52
61
FulfillmentMaves +25
87
62
Contract termsEven
55
55
Maves · left barVida Health · right bar

The numbers

MetricMavesVida Health
WeighScore71.8/10055.2/100
GradeCC
Scorecard rank#89#446
Semaglutide$99/mo (starting dose, first-month rate, compounded)Not disclosed
TirzepatideNot disclosedNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Maves

Graded #89 · C

Strengths

  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer
  • $99/mo first-month intro pricing on semaglutide — among the most aggressive we track
  • All 50 states covered, stated explicitly
  • Both brand (Maves) and parent (Homera Health) disclosed for accountability

Where it loses points

  • 503A pharmacy partner not named (only 'licensed U.S. pharmacies')
  • Tirzepatide pricing not stated on the homepage — only listed as an offering
  • Named medical director / clinical leadership not disclosed
  • Refund and cancellation policy not detailed publicly
  • Corporate address and arbitration venue not disclosed
Vida Health

Graded #446 · C

Strengths

  • Medical Weight Loss program includes anti-obesity GLP-1 medications
  • Pairs medication with behavioral-health coaching and medical management
  • Whole-person care across chronic conditions, sleep, and nutrition
  • Integrates with major health plans, PBMs, and benefit platforms
  • Established virtual chronic-care platform

Where it loses points

  • Distributed mainly via employers and health plans, not direct cash-pay
  • Access usually requires employer or plan sponsorship
  • No public consumer GLP-1 pricing
  • Clinician credentials not detailed publicly
  • Less suited to consumers wanting direct-to-door GLP-1

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard